1. Heparin, urokinase, and ancrod alter neutrophil function
Julie A. Freischlag, MD, Michael D. Colburn, MD, William J. Quiñones-Baldrich, MD, Wesley S. Moore, MD 
Journal of Vascular Surgery 
Volume 16, Issue 4, Pages (October 1992)
DOI: / (92)
Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

2. Fig. 1
Chart shows effect of tested doses of each agent on production of superoxide anion by activated human PMNs at concentration of 2 × 106 cells/ml.
Journal of Vascular Surgery  , DOI: ( / (92) )
Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

3. Fig. 2
Chart shows effect of tested doses of each agent on chemotaxis of human PMNs at a concentration of 2 × 106 cells/ml. Serum from corresponding subject for each experiment was used as chemoattractant. Asterisks denote statistical significance (p < 0.01) compared with control.
Journal of Vascular Surgery  , DOI: ( / (92) )
Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

4. Fig. 3
Chart shows effect of tested doses of each agent on phagocytosis of opsonized zymosan by human PMNs at concentration of 2 × 106 cells/ml. Serum from corresponding subject for each experiment was used to opsonize zymosan particles. Asterisks denote statistical significance (*p < 0.01; **p < 0.05) compared with control.
Journal of Vascular Surgery  , DOI: ( / (92) )
Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions